Approaches to antiviral agents /

Approaches to antiviral agents /

42

Bibliographic Details
Main Author:	Harnden, Michael R.
Format:
Published:	London : MacMillan, 1985
Subjects:	Antiviral agents

Similar Items

Antiviral research : strategies in antiviral drug discovery /
by: LaFemina, Robert L., et al.
Published: (c200)

Successful strategies for the discovery of antiviral drugs /
by: Desai, Manoj C., et al.
Published: (2013)

Antiviral drug discovery for emerging diseases and bioterrorism threats /
by: Torrence, Paul F.
Published: (2005)

Antiviral drugs : from basic discovery through clinical trials /
by: Kazmierski, Wieslaw M.
Published: (c201)

Antiviral chemotherapy : design of inhibitors of viral functions /
by: Gauri, K. K., et al.
Published: (1981)

New concepts of antiviral therapy / [electronic resource]
by: Holzenburg, Andreas, et al.
Published: (2006)

Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide
by: Jackman, Joshua A., et al.
Published: (2020)

ROTAVIRAL INFECTION IN CHILDREN: CLINICAL PRESENTATION AND ASSESSMENT OF ANTIVIRAL TREATMENT EFFICACY
by: E. V. Mikhailova, et al.
Published: (2012-11-01)

Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
by: Tushar Saha, et al.
Published: (2025-02-01)

Antiviral Properties of Basidiomycetes Metabolites
by: A. V. Avtonomova, et al.
Published: (2020-05-01)

Cancer-causing viruses and their inhibitors /
by: Gupta, Satya Prakash, editor
Published: (2014)

Advanced therapy for hepatitis C /
by: McCaughan, Geoffrey W., et al.
Published: (2012)

Cloning and overexpression of influenza A H1N1 NS1 protein in Escherichia coli /
by: Ong, Lih Lih, 1983-, et al.
Published: (2010)

Cloning and overexpression of influenza A H1N1 NS1 protein in Escherichia coli [electronic resource] /
by: Ong, Lih Lih, 1983-
Published: (2010)

Antiviral cystine knot α-amylase inhibitors from alstonia scholaris
by: Nguyen, Phuong Quoc Thuc, et al.
Published: (2018)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
by: K. Yu. Kokina, et al.
Published: (2021-04-01)

In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus
by: Pâmela Jóyce Previdelli da Conceição, et al.
Published: (2025-02-01)

Fitokimyasalların Antiviral Etkileri
by: Tuğba Demir, et al.
Published: (2021-07-01)

Antiviral Activity of Panavir in Experimental Infection Due to Morbillivirus in Cell Cultures
by: S. G. Markushin, et al.
Published: (2020-05-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

Design of anti-AIDS drugs /
by: De Clercq, Erik, et al.
Published: (1990)

Risk of hepatocellular carcinoma with tenofovir vs entecavir treatment for chronic hepatitis B virus: a reconstructed individual patient data meta-analysis
by: Tan, Darren Jun Hao, et al.
Published: (2023)

Insights from a community-based survey on factors influencing acceptance and uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 antiviral medication in Singapore
by: Soh, Alexius Matthias Sheng En, et al.
Published: (2024)

Propolisin Kimyasal İçeriği ile Antibakteriyel, Antiviral ve Antioksidan Aktivitesi
by: Pınar COŞKUN, et al.
Published: (2020-12-01)

Life saving drugs : the elusive magic bullet /
by: 217893 Mann, John, et al.
Published: (2004)

Antiviral Action of Sulfated Polysaccharides
by: I. D. Makarenkova, et al.
Published: (2020-05-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

The Influence of the AgNPs Ligand on the Antiviral Activity Against HSV-2
by: Tomaszewska E, et al.
Published: (2025-03-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

Study of the Antiviral Activity of Adamantane-Containing Chemical Compounds
by: I. I. LYUBIMOV, et al.
Published: (2022-11-01)

Antiviral roles of eosinophils in asthma and respiratory viral infection
by: Hisashi Sasaki, et al.
Published: (2025-02-01)

New Insights into Antiviral Natural Formulations: Biopolymeric Films for the Prevention and Treatment of a Wide Gamma of Viral Infections
by: Victoria Belén Ayala-Peña, et al.
Published: (2025-02-01)

Antiviral treatment for viral pneumonia: current drugs and natural compounds
by: Hao Zhang, et al.
Published: (2025-03-01)

Antiviral Activity of Kagocel® on the Model of Experimental Lethal Influenza Infection
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

Study of the Antiviral Activity of Drugs and Their Combination Against the Influenza A Virus
by: E. N. Vetrova, et al.
Published: (2025-02-01)

Recent insights and advances in gut microbiota's influence on host antiviral immunity
by: Ying Liu, et al.
Published: (2025-02-01)

Experimental Investigation of Ingavirin® Antiviral Activity Against Human Parainfluenza Virus
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice
by: V. V. Zarubaev, et al.
Published: (2020-05-01)